Genetics of morphological hip abnormalities and their implications for osteoarthritis: a scoping review

Lainey G Bukowiec1,2, Elizabeth S Kaji2, John A Koch2

  • 1Mayo Clinic Department of Orthopedic Surgery, 200 First St, Rochester, MN 55905, United States.

PubMed

Insights

Morphological hip abnormalities (MHAs) can lead to early osteoarthritis and impaired function. Understanding the genetic and biomechanical factors is key to developing personalized treatments and preventing long-term hip problems.

Area of Science:

  • Orthopedics and Genetics
  • Biomechanical Engineering

Background:

  • Morphological hip abnormalities (MHAs) significantly impact hip prognosis, leading to early osteoarthritis and functional impairment.
  • Developmental dysplasia of the hip (DDH) and femoroacetabular impingement (FAI) are key MHAs resulting from abnormal femoral head coverage.
  • These conditions alter hip biomechanics, causing damage, pain, and accelerated degeneration.

Purpose of the Study:

  • To explore the genetic and biomechanical underpinnings of morphological hip abnormalities (MHAs).
  • To understand the mechanisms linking hip morphology to osteoarthritis.
  • To identify potential pathways for personalized interventions and early detection.

Main Methods:

  • Review of genetic research linking specific genes (e.g., COL1A1, MMP13, IL-6, ADAMTS4, FRZB, TGF-β1) to MHAs and osteoarthritis.
  • Integration of imaging techniques, including statistical shape modeling, to analyze 3D hip morphology.
  • Biomechanical analysis to understand the impact of MHAs on joint function.

Main Results:

  • Identified numerous genes implicated in osteoarthritis, DDH, and FAI, highlighting a genetic component in hip morphology.
  • Established that altered hip biomechanics due to MHAs contribute to structural damage and degeneration.
  • Highlighted the need for multimodal approaches combining genetics, imaging, and biomechanics.

Conclusions:

  • Early detection of MHAs is crucial for preventing early-onset osteoarthritis.
  • Multimodal strategies integrating genetics, advanced imaging, and biomechanics are essential for understanding disease subtypes and developing personalized treatments.
  • Further research into genetic factors of other hip conditions like Slipped Capital Femoral Epiphysis and Legg-Calvé-Perthes disease is warranted.